{"id":"desoximetasone-spray-0-25","safety":{"commonSideEffects":[{"rate":null,"effect":"Skin atrophy"},{"rate":null,"effect":"Striae"},{"rate":null,"effect":"Telangiectasia"},{"rate":null,"effect":"Local irritation or burning"},{"rate":null,"effect":"Folliculitis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Desoximetasone is a synthetic corticosteroid that penetrates skin tissue and binds to intracellular glucocorticoid receptors, leading to reduced production of inflammatory mediators, decreased immune cell infiltration, and suppression of local inflammatory responses. This results in reduced erythema, pruritus, and other signs of dermatological inflammation. The spray formulation allows for convenient topical application to affected areas.","oneSentence":"Desoximetasone is a topical corticosteroid that suppresses inflammatory and immune responses in the skin by binding to glucocorticoid receptors.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:44:20.731Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., eczema, psoriasis, dermatitis)"}]},"trialDetails":[{"nctId":"NCT02985736","phase":"PHASE4","title":"Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray","status":"COMPLETED","sponsor":"Psoriasis Treatment Center of Central New Jersey","startDate":"2016-09","conditions":"Psoriasis","enrollment":20},{"nctId":"NCT02983981","phase":"PHASE4","title":"Topical Psoriasis Study for Patients Receiving Biologic Therapy","status":"COMPLETED","sponsor":"Psoriasis Treatment Center of Central New Jersey","startDate":"2016-03","conditions":"Psoriasis","enrollment":20},{"nctId":"NCT02340169","phase":"PHASE4","title":"Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2015-01-23","conditions":"Plaque Psoriasis","enrollment":129},{"nctId":"NCT03050294","phase":"PHASE4","title":"Evaluating Treatment Resistant Dermatitis TaroIIR","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2017-02-01","conditions":"Atopic Dermatitis, Psoriasis","enrollment":24},{"nctId":"NCT01206387","phase":"PHASE3","title":"Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2010-08","conditions":"Psoriasis","enrollment":120},{"nctId":"NCT01018134","phase":"PHASE2","title":"Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2009-11","conditions":"Psoriasis","enrollment":151},{"nctId":"NCT01206660","phase":"PHASE3","title":"Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque Psoriasis","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2010-08","conditions":"Psoriasis","enrollment":120},{"nctId":"NCT01043393","phase":"PHASE2","title":"Desoximetasone Spray 0.25%, Hypothalamic Pituitary Adrenal (HPA) Axis Study","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2010-02","conditions":"Psoriasis","enrollment":24}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Desoximetasone"],"phase":"marketed","status":"active","brandName":"Desoximetasone Spray 0.25%","genericName":"Desoximetasone Spray 0.25%","companyName":"Sun Pharmaceutical Industries, Inc.","companyId":"sun-pharmaceutical-industries-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Desoximetasone is a topical corticosteroid that suppresses inflammatory and immune responses in the skin by binding to glucocorticoid receptors. Used for Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., eczema, psoriasis, dermatitis).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}